1.00824

Vanadium(V) oxide

EMPLURA^®

• Sinónimos: Vanadium(V) oxide, Vanadic anhydride, Vanadium pentoxide
• Fórmula empírica (notación de Hill): O₅V₂
• Número de CAS: 1314-62-1
• Peso molecular: 181.88
• MDL number: MFCD00011457
• UNSPSC Code: 12352303
• EC Index Number: 215-239-8
• NACRES: NA.21

Propiedades

• Quality Level: 200
• product line: EMPLURA^®
• assay: ≥99.0%
• form: solid
• potency: 400-500 mg/kg LD₅₀, oral (Rat); >2000 mg/kg LD₅₀, skin (Rat)
• impurities: ≤0.002% Chloride (Cl); ≤0.01% Fe (Iron); ≤0.01% Phosphate (PO₄); ≤0.01% Sulfate (SO₄); ≤0.01% Total nitrogen (N)
• pH: 4 (20 °C, 50 g/L in H₂O, slurry)
• bp: 1750 °C/1013 hPa (decomposition)
• mp: 690 °C
• density: 3.36 g/cm³ at 20 °C
• bulk density: 400‑600 kg/m³
• storage temp.: 2-30°C
• InChI: 1S/5O.2V
• InChI key: GNTDGMZSJNCJKK-UHFFFAOYSA-N

Descripción

Application

• Demethoxycurcumin in cancer research: This compound is significantly researched for its efficacy in cancer treatment, particularly in cell signaling pathways that govern cell proliferation and apoptosis. Studies indicate its potential in targeting NF-kB pathways, commonly associated with cancer cell survival (Ullah et al., 2024).

Analysis Note

Assay: ≥ 99.0 %
Chloride (Cl): ≤ 0.002 %
Phosphate (PO₄): ≤ 0.01 %
Sulfate (SO₄): ≤ 0.01 %
Total nitrogen (N): ≤ 0.01 %
Fe (Iron): ≤ 0.01 %

Legal Information

EMPLURA is a registered trademark of Merck KGaA, Darmstadt, Germany

Información de seguridad

• pictograms: GHS06,GHS08,GHS09
• signalword: Danger
• hcodes: H301 - H330 - H335 - H341 - H350 - H361fd - H362 - H372 - H411
• pcodes: P202 - P260 - P263 - P264 - P273 - P304 + P340 + P310
• Hazard Classifications: Acute Tox. 2 Inhalation - Acute Tox. 3 Oral - Aquatic Chronic 2 - Carc. 1B - Lact. - Muta. 2 - Repr. 2 - STOT RE 1 Inhalation - STOT SE 3
• target_organs: Respiratory system, Respiratory Tract
• Storage Class: 6.1B - Non-combustible, acute toxic Cat. 1 and 2 / very toxic hazardous materials
• wgk_germany: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable